作者：
O'Brien,S. [1]
;
Furman,R.R. [2]
;
Coutre,S.E. [3]
;
Sharman,J.P. [4]
;
Burger,J.A. [5]
;
Blum,K.A. [6]
;
Grant,B. [7]
;
Richards,D.A. [8]
;
Coleman,M. [9]
;
Wierda,W.G. ;
Jones,J.A. ;
Zhao,W. ;
Heerema,N.A. ;
Johnson,A.J. ;
Izumi,R. ;
Hamdy,A. ;
Chang,B.Y. ;
Graef,T. ;
Clow,F. ;
Buggy,J.J. ;
James,D.F. ;
Byrd,J.C.
作者单位：
Pharmacyclics, Sunnyvale, CA, United States
[1]
Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
[2]
Vermont Cancer Center, University of Vermont, VT, United States
[3]
Willamette Valley Cancer Institute and Research Center/US Oncology Research, Springfield, OR
[4]
Department of Pathology, The Ohio State University, Columbus, OH, United States
[5]
Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, United
[6]
Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medical College, New York
[7]
Division of Hematology and Stanford Cancer Center, Stanford University School of Medicine, Stanford
[8]
Texas Oncology, US Oncology Research, Tyler, TX, United States
[9]
发布时间
2014-03-22
换一批
